Phil Roe

Update: Martin-, Heritage-backed Wellvana files further $10MM capraise

Jul 21, 2023 at 04:33 pm by miltcapps

Updated: Wellvana filed July 21, 2023 with SEC on a further $10MM raise. (This brings total-in since inception to at least $150M). 27 March 2023: Martin Ventures announced in.... Read More

A message for Readers from the VNC Publisher

Apr 25, 2017 at 04:45 pm by miltcapps

Milt Capps Dear Readers -- VNC recently entered a brief transition period, moving toward a Membership-access model for Venture Nashville Connections, entering its 9th.... Read More

Former VC Les Wilkinson now Hashed Health chief development officer

Apr 25, 2017 at 03:30 pm by miltcapps

LES WILKINSON, formerly managing director of Martin Ventures, is now chief development officer for Hashed Health, the startup information technology company focused on commerc.... Read More

Nashville startups scouted by Cedars-Sinai<br>Healthcare Accelerator with Techstars

Mar 17, 2017 at 04:03 pm by miltcapps

LOS ANGELES-based Cedars-Sinai Healthcare Accelerator Powered by Techstars will hold a seminar and office hours at the Nashville Entrepreneur Center on March 28. Program Manag.... Read More

Briefing: Hashed Health to convene blockchain consortium in Nashville

Mar 13, 2017 at 04:30 pm by miltcapps

HASHED HEALTH, the Nashville startup backed by Martin Ventures and Fenbushi Capital, will in September convene in Music City its growing consortium of healthcare companies int.... Read More

VC's Lucro Marketplace for Healthcare solutions seeks array of partners

Dec 01, 2015 at 02:30 pm by miltcapps

Updated 17 Sept. 2018 - Frisco/Dallas-based Valify, backed by Frist Cressey, Step5 Capital, Meridian St. Capital, bought Martin Ventures-backed Lucro, it announced yesterday..... Read More

LifeScience: TNInvestco-funded Diagnovus' growth may lie in hands of East/West coastal investors

Dec 09, 2013 at 11:39 am by miltcapps

Updated: Jan. 6, 2015: Aegis Sciences Corp. acquired Diagnovus, story here.-Ed. FRESH ON THE HEELS of startup Diagnovus' introduction of its second molecular-diagnostic assay,.... Read More